Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-82.27	33.09	186.70
Graham Fair Price	73.57	1.59	0.92
PEG	-92.28	0.13	-1.65
Price/Book	-12.63	1.56	1.78
Price/Cash Flow	-67.92	54.05	168.49
Prices/Earnings	-72.92	26.98	99.61
Price/Sales	-15.42	2.03	2.41
Price/FCF	-67.92	54.05	168.49
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-19.54	0.09	0.11
Operating Margin	-146.70	< 0.005	< 0.005
ROA	222.47	< 0.005	< 0.005
ROE	< 0.005	0.01	222.61
ROIC	< 0.005	< 0.005	373.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.05	-99.07
Dividends QOQ	0.49	0.96	93.63
EBIT QOQ	0.95	-1.49	55.92
EPS QOQ	-0.60	2.12	250.91
FCF QOQ	-0.76	1.66	117.05
Revenue QOQ	-0.03	< 0.005	-76.13
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	49.20	49.82	1.25
Days Sales Outstanding (DSO)	70.77	78.25	10.57
Inventory Turnover	1.83	1.81	-1.24
Debt/Capitalization	0.76	0.77	0.60
Quick Ratio	0.77	0.81	5.31
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.89	7.44	157.98
Cash	2.64	2.39	-9.46
Capex	-0.36	0.31	-13.07
Free Cash Flow	0.03	0.08	163.23
Revenue	2.14	2.13	-0.17
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.07	1.01	-5.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	116.33	22.09	-81.01
Naive Interpretation	Member

06 - Financial Health · Bad

Rating